Limbix

About:

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Website: https://www.limbix.com

Twitter/X: LimbixHealth

Top Investors: Plug and Play, Gaingels, Sequoia Capital, Mana Ventures, Maverick Ventures

Description:

Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.

Total Funding Amount:

$31M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2016-10-01

Contact Email:

info(AT)limbix.com

Founders:

Ben Lewis, Jonathan Sockell, Scott Satkin

Number of Employees:

11-50

Last Funding Date:

2021-12-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai